Biologics Development and Manufacturing Trends, Part 1

Published on: 

PharmTech Multimedia

Eric Langer, Managing partner at BioPlan Associates, speaks with Pharmaceutical Technology about the results from the 12th annual BioPlan Associates survey, and single use technology adoption.

Eric Langer, Managing Partner at BioPlan Associates, spoke with Pharmaceutical Technology about the results from the 12th annual BioPlan Associates survey, and single use technology adoption. 

 

Related Content:

Biologic DrugsManufacturingDosage Forms
The Making of mRNA
Increasing mRNA Product Stability with Lyophilization
Bristol Myers Squibb to Access Cellares' Cell Therapy Manufacturing Platform in New $380 Million CAR-T Cell Therapy Deal